Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

PCSA US Equity

Processa Pharmaceuticals, Inc.Health Care · Pharmaceutical Preparations · CIK 1533743 · FY ends Dec 31
$2.15
+0.05 (+2.38%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-1813GSchedule 13G filed — ≥5% beneficial owner (passive) · by Soleus Capital Master Fund, L.P.sec.gov ↗
2026-08-048-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-08-048-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-298-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-298-K 5.03Amendments to articles of incorporation or bylaws; fiscal year changesec.gov ↗
2026-07-298-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-298-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-07-298-K 2.01Completion of acquisition or disposition of assetssec.gov ↗
2026-07-298-K 1.02Termination of a material definitive agreementsec.gov ↗
2026-07-298-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-29

Every row is a filed document, checked against its EDGAR index.